These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsAs an investor, what you need to do at this point of time is this: A bit of extra work in terms of stock-picking so that you avoid anxiety ...
17 Sep, 2026, 11.05 AM IST
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIn the equity market, it is generally good to keep one eye on risk management. But there are times when it becomes a must-do. We are curren...
03 Sep, 2026, 11.55 AM IST
Stocks in news: Groww, Tata Motors PV, Cipla, Varun Beverages and Axis BankThe Indian equity market experienced a positive turnaround on Tuesday, August 25, highlighted by the Nifty 50 making a robust recovery. Ant...
26 Aug, 2026, 06.00 AM IST
Strides Pharma Science shares jump 9% after USFDA EIR for Bengaluru facilityStrides Pharma Science shares rise sharply on Thursday after the USFDA issued an Establishment Inspection Report (EIR) for its Bengaluru fa...
20 Aug, 2026, 11.09 AM IST
- Navin Fluorine shares surge 8% after Q1 profit more than doubles. Should you buy, sell or hold?
Navin Fluorine shares surged nearly 8% after the company posted a strong Q1FY27 performance, with profit more than doubling and revenue ris...
06 Aug, 2026, 10.36 AM IST
Hikal commissions cGMP pilot plant in Pune to strengthen pharmaceutical developmentHikal has commissioned an enhanced cGMP pilot plant at its Pune campus to strengthen its integrated capabilities for pharmaceutical develop...
22 Jul, 2026, 12.01 PM IST
Over 67,000 cases of deodorants sold at Walmart, Amazon recalled due to 'cGMP deviations'. What is it?Over 67,000 cases of Power Stick deodorant sold at major retailers like Walmart, Amazon, and Dollar Tree have been voluntarily recalled. Th...
20 Jul, 2025, 11.37 AM IST
USFDA warns Cipla for lapses in manufacturing practices at Pithampur facilityAccording to an exchange filing, the drug manufacturer was given a detailed breakdown of the lapses in methods followed at the facility by ...
20 Nov, 2023, 08.30 AM IST
USFDA inspection of Biocon's drug substance unit at Bengaluru completeThe week-long audit concluded without any observations and no Form 483 was issued, it added.
24 Sep, 2018, 02.19 PM IST
Making Ranbaxy units cGMP compliant time consuming: Sun PharmaThe company expects to complete the remediation steps in at least one of these facilities in this fiscal, Sun Pharma Managing Director Dili...
21 Aug, 2016, 11.18 AM IST
Novartis gets USFDA warning letter for two plants in IndiaSandoz, the generic drug arm of Swiss drug major Novartis, has received a warning letter from the US health regulator for violations of cur...
28 Oct, 2015, 07.04 PM IST
Jubilant arm recalls Pantoprazole Sodium drug from US marketThe US FDA cites the reason of recall as "cGMP deviations, oral products were not manufactured in accordance with good manufacturing practi...
21 May, 2013, 04.10 AM IST
- Sun Pharma Q1 net zooms 244 pc to Rs 564.32 cr
Sun Pharmaceutical Industries today reported a 244.43 per cent jump in net profit at Rs 564.32 crore for the quarter ended June.
28 Jul, 2010, 04.50 PM IST
- US FDA issues warning letter to Ranbaxy's American subsidiary
The US Food and Drug Administration issued a warning letter to Ranbaxy Labs' American subsidiary for violating current good manufacturing p...
24 Dec, 2009, 05.34 PM IST
- Ranbaxy to market Lisinopril tablets in Canada
Ranbaxy Laboratories has got approval from Health Canada, Therapeutic Products Directorate to manufacture and market Lisinopril 5, 10 and 2...
22 Oct, 2007, 02.18 PM IST
- HCL launches ELM app for pharma
HCL Technologies Ltd has announced the launch of its web-based application 'Equipment Log Manager', designed to cater to the pharmaceutical...
31 Aug, 2006, 04.30 PM IST
- HCL launches ELM application for pharma industry
Leading IT services provider HCL Technologies Ltd on Thursday announced the launch of its web-based application 'Equipment Log Manager', de...
31 Aug, 2006, 04.10 PM IST